Evidence map›Paper›PMID 39926359›Full record

ReviewTransplant international : official journal of the European Society for Organ Transplantation2025

Donors With Previous Malignancy: When Is It Safe to Proceed With Organ Transplantation?

Vitor Turra, Joao Manzi, Sarah Rombach, Simone Zaragoza, Raphaella Ferreira, Giselle Guerra, Kendra Conzen, Trevor Nydam, Alan Livingstone, Rodrigo Vianna and 1 more

Abstract readReview
In one paragraph

Review in Transplant international : official journal of the European Society for Organ Transplantation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Transplant International: Looking Back at 2025, Looking Forward to 2026.Transplant international : official journal of the European Society for Organ Transplantation · 2026
    Article
  5. Oncology and Solid Organ Transplantation: New Biological and Clinical Insights.Transplant international : official journal of the European Society for Organ Transplantation · 2026
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Vitor TurraMiami Transplant Institute, Jackson Memorial Hospital, University of Miami, Miami, FL, United States.
Joao ManziMiami Transplant Institute, Jackson Memorial Hospital, University of Miami, Miami, FL, United States.
Sarah RombachMiami Transplant Institute, Jackson Memorial Hospital, University of Miami, Miami, FL, United States.
Simone ZaragozaMiami Transplant Institute, Jackson Memorial Hospital, University of Miami, Miami, FL, United States.
Raphaella FerreiraHCA Healthcare-HealthOne Internal Medicine Residency Program, Sky Ridge Medical Center, Denver, CO, United States.
Giselle GuerraMiami Transplant Institute, Jackson Memorial Hospital, University of Miami, Miami, FL, United States.
Kendra ConzenDepartment of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Trevor NydamDepartment of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Alan LivingstoneSylvester Comprehensive Cancer Center, University of Miami, Miami, FL, United States.
Rodrigo ViannaMiami Transplant Institute, Jackson Memorial Hospital, University of Miami, Miami, FL, United States.
Phillipe AbreuDepartment of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The growing number of organ donors in the United States, from 14,011 in 2012 to 21,374 in 2022, highlights progress in addressing the critical issue of organ shortages. However, the demand remains high, with 17 patients dying daily while on the waiting list. As of August 2023, over 103,544 individuals are awaiting transplants, predominantly for kidneys (85.7%). To expand the donor pool, the inclusion of elderly donors, including those with a history of malignancies, is increasingly considered. In 2022, 7% of all donors were aged 65 and above, despite the complexities their medical histories may introduce, particularly the risk of donor-transmitted cancer (DTC). This review examines the challenges and potential benefits of using donors with known malignancy histories, balancing the risks of DTC against the urgency for transplants. A critical analysis is presented on current knowledge and the decision-making processes that consider cancer types, stages, and patient survival outcomes. The goal is to identify missed opportunities and improve strategies for safe and effective organ transplantation from this donor demographic.

Indexed as

NeoplasmsOrgan TransplantationTissue DonorsAgedDonor SelectionHumansTissue and Organ ProcurementWaiting Listscancerdonormalignancyrisktransplant surgery

Identifiers

PMID39926359
PMCPMC11802283

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.